Written on 07.01.2014 - Personnel
You have these options:

Lubben named new President of Reverdia

Marcel Lubben

Effective 1 January 2014, Marcel Lubben has been appointed as President of Reverdia, a joint venture between Royal DSM and Roquette Frères. Reporting to the Reverdia board, Lubben will be responsible for developing and managing the sustainable succinic acid manufacturer into the next phase of growth.

Lubben replaces General Manager Will van den Tweel, who successfully led the start-up of Reverdia. Van den Tweel drove the joint collaboration between Roquette and DSM on Biosuccinium and was one of the founders of DSM’s innovation initiatives into Industrial Biotechnology. An announcement about his transfer will be made in due course.

Lubben holds a PhD in Organic Chemistry from the University of Groningen, the Netherlands, and joined DSM in 1994. He held positions in Research, Business Development and Marketing & Sales in DSM Pharma Chemicals and DSM Biologics before transitioning into the industrial biotechnology sector. In 2009, he was appointed Managing Director Licensing for DSM and became Managing Director Venturing & Licensing in 2011. In 2012 he became Vice President Bio-based Chemicals & Materials, and he served as a member of the Reverdia board from mid-2012 until the end of 2013.